Lopes, Nair
Salta, Sofia
Flores, Bianca Troncarelli
Miranda-Gonçalves, Vera
Correia, Margareta P.
Gigliano, Davide
Guimarães, Rita
Henrique, Rui
Jerónimo, Carmen
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (UID/DTP/0076/POCI-01-0145-FEDER-006868, https://doi.org/10.544999/SFRH/BD/143717/2019, UIDP/00776/2020, CEECINST/00091/2018)
Instituto Português de Oncologia do Porto (CI‐IPOP/PD/Kymab, BF.CBEG CI-IPOP- 27-2016)
Article History
Received: 26 April 2024
Accepted: 21 June 2024
First Online: 3 August 2024
Declarations
:
: This study has been approved by the Institutional Review Board (Comissão de Ética para a Saúde) of IPO Porto (CES 202/017). All the procedures involving the use of human samples were in accordance with the national ethical standards and following the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: The authors declare that they have no competing interests.